West Pharmaceutical Services, Inc. (NYSE:WST) announces a share repurchase program. Under the program, the company will repurchase up to 650,000 shares of its common stock. The repurchase program is expected to be completed by December 31, 2022.
West Pharmaceutical Services, Inc.
Equities
WST
US9553061055
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
322.6 USD | +0.52% |
|
-2.07% | -8.39% |
07-01 | West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell Midcap Value Index | CI |
07-01 | West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell 3000 Value Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.39% | 23.5B | |
-5.50% | 181B | |
-5.79% | 99.52B | |
-6.59% | 65.82B | |
-8.38% | 45.21B | |
+8.42% | 43.85B | |
+11.01% | 42.17B | |
+10.97% | 28.75B | |
+18.54% | 25.39B | |
-11.25% | 22.22B |
- Stock Market
- Equities
- WST Stock
- News West Pharmaceutical Services, Inc.
- West Pharmaceutical Services, Inc. announces an Equity Buyback for 650,000 shares.